These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 1455197)

  • 1. Triple therapy of Helicobacter pylori infection in peptic ulcer. A 12-month follow-up study of 93 patients.
    Seppälä K; Färkkilä M; Nuutinen H; Hakala K; Väänänen H; Rautelin H; Kosunen TU
    Scand J Gastroenterol; 1992 Nov; 27(11):973-6. PubMed ID: 1455197
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacological effects of metronidazole+tetracycline+bismuth subcitrate versus omeprazole+amoxycillin+bismuth subcitrate in Helicobacter pylori-related gastritis and peptic ulcer disease.
    Park KN; Hahm JS; Kim HJ
    Eur J Gastroenterol Hepatol; 1994 Dec; 6 Suppl 1():S103-7. PubMed ID: 7735924
    [TBL] [Abstract][Full Text] [Related]  

  • 3. One-week ranitidine bismuth citrate versus colloidal bismuth subcitrate-based anti-Helicobacter triple therapy: a prospective randomized controlled trial.
    Kung NN; Sung JJ; Yuen NW; Li TH; Ng PW; Lai WM; Lui YH; Lam KN; Choi CH; Leung EM
    Am J Gastroenterol; 1999 Mar; 94(3):721-4. PubMed ID: 10086657
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ranitidine versus colloidal bismuth subcitrate in combination with amoxicillin and metronidazole for eradicating Helicobacter pylori in patients with duodenal ulcer.
    Carpintero P; Blanco M; Pajares JM
    Clin Infect Dis; 1997 Nov; 25(5):1032-7. PubMed ID: 9402352
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effective treatment after failure of omeprazole plus amoxycillin to eradicate Helicobacter pylori infection in peptic ulcer disease.
    Labenz J; Rühl GH; Bertrams J; Börsch G
    Aliment Pharmacol Ther; 1994 Jun; 8(3):323-7. PubMed ID: 7918928
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anti-Helicobacter pylori treatment in bleeding ulcers: randomized controlled trial comparing 2-day versus 7-day bismuth quadruple therapy.
    Kung NN; Sung JJ; Yuen NW; Ng PW; Wong KC; Chung EC; Lim BH; Choi CH; Li TH; Ma HC; Kwok SP
    Am J Gastroenterol; 1997 Mar; 92(3):438-41. PubMed ID: 9068464
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Effectiveness of triple therapy to eradicate H. pylori in patients after failed therapy with omeprazole/amoxicillin].
    Zala G; Schwery S; Giezendanner S; Flury R; Wüst J; Meyenberger C; Wirth HP
    Schweiz Med Wochenschr; 1996 Feb; 126(5):153-8. PubMed ID: 8685685
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Three treatment schemes with colloidal bismuth subcitrate (Q-ULCER) in peptic ulcer with Helicobacter pylori.
    Suárez MS; González Cansino J; Velasco Ilizalde C; Sabatier CA; Castillo Hernández J
    Arch Med Res; 1999; 30(1):55-9. PubMed ID: 10071426
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Highly effective twice-daily triple therapies for Helicobacter pylori infection and peptic ulcer disease: does in vitro metronidazole resistance have any clinical relevance?
    Lerang F; Moum B; Haug JB; Tolås P; Breder O; Aubert E; Høie O; Søberg T; Flaaten B; Farup P; Berge T
    Am J Gastroenterol; 1997 Feb; 92(2):248-53. PubMed ID: 9040200
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of omeprazole and amoxicillin plus metronidazole on the eradication of Helicobacter pylori and the healing of duodenal ulcer: comparison with a historical control.
    Schütze K; Hentschel E; Hirschl AM
    Hepatogastroenterology; 1999; 46(28):2358-62. PubMed ID: 10521998
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Omeprazole/amoxicillin versus triple therapy for Helicobacter pylori in duodenal ulcer disease: two-year follow-up of a prospective randomized study.
    Labenz J; Stolte M; Peitz U; Tillenburg B; Köhl H; Becker T; Börsch G
    Z Gastroenterol; 1995 Oct; 33(10):590-3. PubMed ID: 7502551
    [TBL] [Abstract][Full Text] [Related]  

  • 12. One week eradication regimen for Helicobacter pylori.
    Logan RP; Gummett PA; Misiewicz JJ; Karim QN; Walker MM; Baron JH
    Lancet; 1991 Nov; 338(8777):1249-52. PubMed ID: 1682653
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of a new bismuth-free triple therapy in nude mice and humans.
    Karita M; Tsuda M; Okita K; Sugiyama T; Nakazawa T
    Eur J Gastroenterol Hepatol; 1995 Aug; 7 Suppl 1():S31-4. PubMed ID: 8574732
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recrudescence of Helicobacter pylori infection in patients with healed duodenal ulcer after treatment with different regimens.
    Xia HX; Gilvarry J; Beattie S; Hamilton H; Keane CT; Sweeney EC; O'Morain CA
    Am J Gastroenterol; 1995 Aug; 90(8):1221-5. PubMed ID: 7639218
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of the efficacy of 1-day high-dose quadruple therapy versus 7-day triple therapy for treatment of Helicobacter pylori infection.
    Zheng Q; Pan Y; Zhang L; Xiao SD
    Chin J Dig Dis; 2005; 6(4):202-5. PubMed ID: 16246231
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Low dose, short duration therapy for the eradication of Helicobacter pylori in patients with duodenal ulcer.
    Iser JH; Buttigieg RJ; Iseli A
    Med J Aust; 1994 Feb; 160(4):192-6. PubMed ID: 7906009
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metronidazole resistance: a predictor of failure of Helicobacter pylori eradication by triple therapy.
    Midolo PD; Lambert JR; Turnidge J
    J Gastroenterol Hepatol; 1996 Mar; 11(3):290-2. PubMed ID: 8742929
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ribotyping patterns and emergence of metronidazole resistance in paired clinical samples of Helicobacter pylori.
    Rautelin H; Tee W; Seppälä K; Kosunen TU
    J Clin Microbiol; 1994 Apr; 32(4):1079-82. PubMed ID: 8027316
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The effect of "triple therapy" on the eradicating of H. pylori and the healing of a duodenal ulcer. The initial study and 6 months later].
    Gisbert JP; Boixeda D; de Rafael L; Martín de Argila C; Bermejo F; García Plaza A
    Rev Esp Enferm Dig; 1995 Mar; 87(3):193-8. PubMed ID: 7742047
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Eradication of Helicobacter pylori in peptic ulcer and chronic gastritis. A randomized clinical trial].
    Rodríguez Hernández H; Sánchez Anguiano LF; Quiñones E
    Rev Gastroenterol Mex; 1998; 63(1):21-7. PubMed ID: 10068745
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.